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The class II MHC-encoded molecules, expressed primarily by B lymphocytes,
macrophages, and certain other cell types, serve as target molecules for recog-
nition by T helper/inducer lymphocytes . The T helper/inducer cells play a
critical role in regulating both cellular and humoral immunity, and thus, the
antigen-specific activation of these cells triggered by the engagement of the
receptor on the T cell with its ligand, an ill-defined complex of processed antigen
and class II MHC molecule, is one of the key events in the activation of an
immune response . It is clear that the extensive natural polymorphism of class II
molecules has some relevance to their function . In the mouse, the failure ofsome
strains to respond to certain antigens is a property of the class II alleles, and in
man, susceptibility to certain disease states correlates significantly with HLA class
II type . To explore the relationship between the sequence diversity and function
ofmurine class II I-A molecules, we have produced a series of in vitro serologi-
cally selected cell lines expressing mutant I-Ak molecules (1) . In this report we
will describe the DNA sequence analysis of four of our collection ofmutant cell
lines . Each of the major serologic epitopes on the Ak k polypeptide has been altered
in one or more of the four mutants described in this report . In addition, these
four mutants exhibit a broad spectrum of functional defects when used to
stimulate a panel of T hybridomas of various specificities . The DNA sequence
analysis of the I-Ak k gene from each mutant has revealed that each has sustained
a single amino acid substitution and that all four independent substitutions have
occurred within or near only one of the four variable regions defined in the 0,
domain of the Aß polypeptide by allelic comparisons . These data strongly suggest
that this one variable region is the major determinant of alloantigenicity on the
Ak # polypeptide .
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Materials and Methods
Cell Lines .
￿
Mutants were obtained by a protocol of negative and positive selection
using a panel of anti-I-Ak mAbs after ethylmethanesulfonate mutagenesis of the parental
TA3 cells, as has been described (1). All cell lines have been cloned and subsequently
maintained in RPMI 1640 supplemented with 10% FCS, 2 mM glutamine, 10-4 M 2-ME,
10mM Hepes, and antibiotics at 37 °C in a humidified atmosphere of5% C02 in air .
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FIGURE 1 . The sequencing strategy for the exons of the Ap gene encoding the external
domains of the Ap polypeptide. Only that portion of the gene encoding the external domains
of the mature Ap polypeptide is pictured . Regions encoding sequence present in the mature
protein are denoted by heavy shading and the region encoding the signal peptide is denoted
by hatched shading . Numbers beneath the heavily shaded areas refer to the amino acid residues
encoded by each region . The restriction sites cut by Pst I (P) and Xma I (X) are indicated
along with the approximate sizes of the restriction fragments cloned for sequencing.
Serologic Phenotypes.
￿
Serologic phenotypes of the cell lines were analyzed by indirect
immunofluorescence on a flow cytometer (FACS IV) after staining under saturating
conditions with various I-A'-reactive mAbs as previously described (1) . Fluorescence
intensity was measured using a logarithmic amplifier and quantitated by the comparison
of peak channel numbers. Antibodies 10-2.16 and 11-3.25 were derived by Oi et al . (2) ;
4-2.1 and 4-2.3 by Harmon et al . (3) ; and 39B, 39E, 39J, 40A, 40M, 40F, and 40L by
Pierres et al . (4) .
Functional Phenotypes .
￿
The ability of the various cell lines to present antigen to a panel
of T hybridomas was assayed by quantitating antigen-specific IL-2 release . The panel of
T hybridomas used included both I-A'`-specific auto- and alloreactive T cells and I-A'`-
restricted antigen-specific T cells . The antigen-reactive hybridomas recognized either
KLH, hen egg lysozyme (HEL)' or OVA . Most of these data have been published
previously (1) . Additional functional studies have been carried out by Drs . E . Rosloniec
and J . Freed, using lysozyme-reactive, I-A'`-restricted T hybridomas (unpublished data) .
In all cases, either the supernatants were titrated for IL-2 activity or supernatants from
titrated numbers of stimulator cells were assayed for IL-2 activity .
1-A" *0 Gene Cloning and SeIuencing.
￿
A bacteriophage lambda clone of the 17-kb Eco RI
fragment containing the A# gene (5) from each mutant was isolated from a size-selected
(16-20 kb) Eco RI genomic library prepared in either Charon 4 or EMBL4 . The A#
insert-containing phage were identified by hybridization with either the pIA r 1 (6) or the
pCA12 plasmid probe kindly provided by Dr . J. Seidman (Harvard Medical School,
Boston, MA) and Dr . L . Hood (California Institute of Technology, Pasadena, CA),
respectively . The pCA12 plasmid consists of the 2.4-kb Hind III fragment of the As gene
that contains exons 1 and 2 and the intervening sequence (7) subcloned into pBR325 .
The mutant Ap genes were digested with Pst I or Xma I or both and the fragments were
cloned into M13mp18 or 19 for nucleotide sequencing by the dideoxy chain termination
method (8) . The approximate sizes of the fragments cloned are indicated in Fig. 1 . The
desired recombinants were identified by hybridization with synthetic oligonucleotides
complementary to intron sequences directly adjacent to the particular exons, based on
published sequence (9) . The same oligonucleotides subsequently were used as primers in
the sequencing reactions . The exons encoding the ,3, and 02 domains were sequenced in
both directions and the leader exon sequenced only in the 3' to 5' direction, as indicated
in Fig . 1 .
Transfection Analysis ofMutant A" * Genes.
￿
The plasmid constructions for the transfec-
tions were as follows . Since Eco RI cuts in the middle of the 3' untranslated exon of the
A# gene, the 17-kb Eco RI fragment containing the Ap gene from the mutant cell lines
' Abbreviation used in this paper:
￿
HEL, hen egg lysozyme .BECK ET AL.
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TABLE I
Serologic Phenotypes ofA" # Mutants
Reactivity with theseArreactive mAbs was analyzed by indirect immunofluorescence as previously
described (1, 32). Reactivity levels are designated as follows: -, no detectable reactivity above
background; ±, weak reactivity (2-10% ofcontrol TA3 level); +, intermediate reactivity (10-30%
of control TA3 level); ++, parental-level reactivity (30-100% of control TA3 level).
* The LD3 mutant appears to have a lower overall expression of I-A°, in addition to the indicated
specific alterations in serologic reactivity, as evidenced by only an intermediate level of reactivity
with all Aa-specific mAbs (data not shown).
LD3, G1, and F16 was cloned into a pBR327 derived plasmid containing a 2.5-kb Barn
HI fragment encoding the complete 3' untranslated region of the As gene (10). For the
mutant K5, the 352-bp Sst II fragment containingthe second exon (,B, domain) was cloned
into pUC18 containing the wild-type Ak gene on a 16-kb Hind III fragment from the
cosmid H-2k1 .1 (11), from which the corresponding wild-type Sst II fragment had been
deleted. The A.k and pMSV-neo (12) plasmids were kindly provided by L. Glimcher,
Harvard School of Public Health, Boston, MA. The plasmid DNAs were transfected into
the M12.C3 cells(13) by electroporation (14) carried out with an apparatus obtained from
Prototype Design Services (Madison, WI).
Results
The TA3 cell line, derived from the fusion of (BALB/c X A/J)FI spleen cells
with the BALB/c B lymphoma cell line M 12.4.1 (15), and thus haploid for the
I-Ak genes, was used as the parent for the isolation of cell lines expressing mutant
I-A' molecules (1). Several different A«- and A'-reactive mAbs have been used
for both the negative and positive selection steps, thus generating an extensive
series of mutant cell lines expressing serologically altered I-Ak molecules. This
selection scheme favors the isolation of variant cell lines expressing Ak molecules
with only limited alterations in either the As or Aa polypeptide (16).
In this report we describe the sequence analysis of four mutants that have
distinct serologic and functional phenotypes. Each of these mutants expresses a
serologically altered Ak polypeptide in association with a wild-type Akk polypep-
tide. With the exception of mAb 4-2 .1, reactivity with each antibody in an
extensive panel of 10 Ak-reactive mAbs has been reduced or eliminated in one
or more of the four mutant cell lines (Table I) . Each cell line retains the capacity
to react at wild-type or near wild-type levels with a panel of Aa reactive mAbs
(data not shown). When analyzed with a panel of Ak-reactive and Ak-restricted
T hybridomas (summarized in Table II), each of the four mutant cell lines has a
distinct functional phenotype, ranging from nearly wild-type (F16 and GI) to
almost completely defective (K5) (reference 1 and Rosloniec, E., J. Freed, B. N .
Beck, and D. J. McKean, unpublished data). All of these mutant cell lines do
retain the capacity to stimulate Ek-restricted T hybridomas at wild-type levels
(data not shown).
Cell line
Allospecifcity: Ia.17
mAb: 10-2.16 11-3.25 4-2.1
Ia.18
4-2 .3 39B
Ia.
39E
l
40A 40M 40F
I-A',f.u
40L
TA3 (parent) ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
LD3* ± - + - t - - - + +
G1 t ++ ++ ++ ++ ++ ++ ++ ++ ++
K5 ++ ++ ++ ++ t - - - ++ ++
F16 ++ ++ ++ - ++ ++ ++ ++ - -436
￿
Ak MUTANT SEQUENCES REVEAL IMMUNODOMINANT REGION
TABLE 11
* The stimulatory capacity of the cell lines was determined as described
in MaterialsandMethods. In almost allcases, the mutant cell lines were
either clearly negative or virtually identicalto the parent TA3 cell line
in stimulatory capacity. The chiefexception is the LD3 cell line, which
occasionally stimulated weak but clearly positive responses as described
in the original report (1).
To ascertain the structural basis for the mutant serologic and functional
phenotypes, a genomic clone of the As gene from each mutant cell line was
obtained in bacteriophage lambda and appropriate restriction fragments were
subcloned into bacteriophage M13 for sequencing. Apartial map of the As gene
is given in Fig. 1 . Only those exons encoding the external domains of the
polypeptide were sequenced. DNA-mediated gene transfer studies (17) have
shown that the alloantigenicity of the A, 6 polypeptide is determined within this
region ofthe gene. Sequence analysis of the first three exons ofthe Ak k genomic
clones revealed that each mutant As gene had sustained a single nucleotide
substitution resulting in a single amino acid substitution in theai domain. LD3
has a Gln to Pro substitution at residue 64, GI a Gln to Arg also at 64, K5 an
Arg to Gln at 70, and F16 a Glu to Asp at 59 (Fig. 2).
To be certain that the mutant gene isolated for sequence analysis was respon-
sible for the mutant phenotype of the cells, the Ak gene from each mutant was
subcloned into a plasmid vector and subsequently cotransfected with a plasmid
containing the wild-type A', gene and the pMSV-neo plasmid (12) into the Ia-
M12.C3 cells (13) by electroporation. Transfectants were selected for resistance
to G418 and subsequently cloned. The I-A'' clones were analyzed for reactivity
with the panel of I-Ak-reactive mAbs by immunofluorescence on a flow cytome-
ter. Fig. 3 shows representative data from a comparison of the parent TA3 cells,
the original F16 mutant cells, and the M12.C3 cells transfected with the Ak kgene
from F16 and the wild-type Aa gene (Tf.F16). No differences were detected
between the original F16 mutant cells and Tf.F16 using any ofthe antibodies in
the panel. In addition, we have obtained completely concordant serologic results
with each of the other A,k e mutants and their respective transfectants (data not
shown). These results indicate that the substitutions in the Ak k genes detected by
DNA sequence analysis are responsible for the mutant serologic phenotypes.
Discussion
Acomparison of the predicted amino acid sequences based on either gene or
cDNA sequences (9, 18) of seven A# alleles reveals four clusters of variable
Functional
Cell line
Phenotypes ofAkMutants
Stimulation of
A°-restricted T
Number tested
A'-reactive and
hybridomas*
Number positive
TA3 (parent) 36 36
LD3 35 20
G1 36 33
K5 23 2
F16 19 17BECK ET AL .
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FIGURE 3 .
￿
Immunofluorescence analysis of TA3, F16, and Tf.F16 . TA3 (A-D), F16 (E-H),
and Tf.F16 (I-L) were stained with the indicated mAb as previously described (1), and with
FITC-protein A . The left peak in each panel is the fluorescence profile of each population
stained with the control mAb and FITC-protein A . Antibodies 10-2.16, 40M, and 40F detect
Ay epitopes and antibody 39J detects an A' . epitope .
residues in the 01 domain (Fig. 2) . The distribution among these clusters of the
substitutions detected in the four serologically selected As mutants LD3, G1, K5,
and F16, is quite striking . All of the substitutions fall near or within the third of
the four clusters of allelicly variable residues . Since the four mutants analyzed
have among them sustained alterations such that the reactivity with all but 1 of
the panel of 10 Arreactive mAbs has been affected, it was surprising to find that
the mutations are clustered into only one of the four variable regions . This
observation strongly suggests that this region of the molecule is serologically
dominant . Consistent with this observation are the results previously reported
on the sequence analysis of the Ak mutant B13 (5) (also derived in vitro from
TA3) and the A' spontaneous in vivo mutant B6.C-H-2 6 "'12 (bm12) (19) . B13 was
independently derived by Glimcher et al . (20) using a selection scheme similar
to that used forLD3. The LD3 and B13 mutants are serologically indistinguish-
able except for their reactivities with mAb 4-2 .3 (our unpublished data). B13 has
a Glu to Lys substitution at position 69 (5) . The Asm'2 polypeptide has three
amino acid substitutions at positions 67, 70, and 71 (19) . Also consistent with
the notion that this region is serologically dominant are the results reported in a
study of three site-directed mutants. Cohn et al . (21) created three Ab mutants
in which they substituted the k residues for the b residues at amino acid position
9 or 13 in the first allelicly defined variable region, or replaced the b residues atBECK ET AL.
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positions 65, 66, 67 (in the third allelicly variable region) with the k haplotype
tyrosine. (The Ak polypeptide has a deletion of two residues in this group of
three). Neither of the substitutions in the first variable region changes the
serologic reactivity of the molecule, whereas the alteration of residues 65-67
leads to the failure of the molecule to be recognized by any of the three Afl-
reactive mAbs tested. Thus, all ofthe available data suggest that the region of
the polypeptide encompassing the variable residues 61-70 is the major deter-
minant of the serologic alloantigenicity.
Attempts have been made to assign alloantigenic epitopes to particular amino
acid residues by comparing allelic sequences and allospecificity patterns. How-
ever, several observations suggest that the structure of alloantigenic epitopes is
complex and that there is not a simple one-to-one correspondence between
alloantigenic epitopes and polymorphic residues. Landais et al. (22) compared
the serology and sequence ofAa polypeptides and predicted that the allospecific-
ities Ia.2 and Ia.19 would be mapped to Arg-57 and Glu-75, respectively, of the
Aa polypeptide. Subsequent analysis of Aa site-directed mutants and in vitro-
selected mutants revealed that both Ia.2 and Ia.19 are determined in large part
by Glu-75, but also, that in the presence of Glu-75, the alteration of two other
residues can result in the loss of both the Ia.2 and Ia.l9 epitopes (23). Clearly,
the structure ofthe Ia.2 and Ia.19 epitopes is determined by the interaction of
several neighboring residues. Of the group of five serologically selected Afl
mutants (four described in thisreport and the B13 mutant described by Glimcher
et al. [20]), only one (K5) has a substitution at a residue that is polymorphic
among the seven sequenced As alleles. However, these As substitutions are all
clustered in a region of the polypeptide that displays considerable allelic varia-
bility, indicatingthe importance ofthis region in determiningthe alloantigenicity
ofthe polypeptide. The complexity ofthe serologic epitopes is further revealed
by the observation that reactivity with several of the mAbs can be altered by
single substitutions at two or more positions. Reactivity with the mAb 10-2.16
(Ia.17) can be altered by substitution at position 64 (LD3 and G1) or at position
69 (1113). Reactivity with the mAbs of allospecificity Ia.l has been affected by
substitution at 64 (LD3), 69 (B13), or 70 (K5). Reactivity with mAb 4-2.3 (Ia.18)
has been affected by substitution at 59 (F16) or 64 (LD3). Furthermore, in three
mutants, more than one allodeterminant has been altered by the single amino
acid substitution. In LD3, Ia.17, Ia.18, and Ia.I have been altered; in B13, Ia.17
and Ia.1; and in F16, Ia.18 and the 40F, 40L epitope. Thus, it is clear that an
alloantigenic epitope iscreated bythe interaction ofseveral residues. In addition,
our data indicate that serologically distinct epitopes may overlap, perhaps by
sharing some contact residues. Alternatively, substitutions in this one region may
induce conformational alterations of distinct epitopes either locally or at a
distance. The selection scheme used to produce each ofthese mutants relied on
random chemical mutagenesis followed by selection against one ofseveral sero-
logic epitopes. It seems unlikely that we would recover multiple independent
substitutions only in the third allelicly variable region ifthe major effect ofthese
substitutions were the induction of conformational changes at distant epitopes
on the molecule. Thus, we favor the interpretation that the serologic epitopes
detected by our panel of mAbs are determined largely by the region of the440
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polypeptide encompassing the third allelicly variable segment, and that the
substitutions that have occurred in the mutant cell lines either have occurred at
contact residues and/or have caused local conformational changes.
The effect of the various amino acid substitutions on the ability of the cell
lines expressing the mutant molecules to stimulate T cells appears to be more
complex than the effect onantibody binding. The four mutants described in this
paper exhibit a range of functional phenotypes from nearly wild-type (F16 and
GI) to nearly completely defective (K5) (Table II, reference 1, and Rosloniec,
E.,J. Freed, B. N. Beck, D. J. McKean, unpublished data). As yet, no pattern of
reactivities has emerged that correlates with either the structural data or the
serologic phenotypes. The limited functional alterations exhibited by the F16
cells may be due to the chemically conservative nature ofthe substitution in this
mutant (Glu to Asp). Although both the LD3 and G1 mutants have substitutions
at residue 64, LD3 cells fail to stimulate approximately half of the T hybrids
tested, while G1 cells stimulate nearly all. The LD3 Gln to Pro substitution might
be expected to have significant impact on the secondary structure of the poly-
peptide due to the imide bond introduced by the proline residue. The K5
substitution has the most dramatic effect on T cell activation: only 2 ofthe 23 T
hybrids assayed are stimulated by these mutant cells. The K5 substitution at
residue 70 (Arg to Gln) appears to be in an important location (directly or
indirectly) for T cell antigen recognition. The T hybrid panel used for this
analysis largely comprisedantigen-reactive andautoreactive Tcells(1). A detailed
evaluation of the ability of the mutants to activate a large panel of T hybrids
with specificity for either a defined peptide antigen or for the A' molecule as
alloantigen has not yet been completed. In a study of the T cell response to
HEL, using a panel of 10 I-A'-restricted HEL-specific T hybridomas anda panel
of8 serologically selected A'and Aa mutant cell lines, five Thybridomas specific
for the HEL peptide 46-61 exhibited four different patterns of stimulation by
the mutant cell lines (24). These data suggest that multiple determinants can be
formed by the association ofeven a sixteen-residue peptideandthe I-Ak molecule,
indirectly indicating the existence ofseveral T cell recognition sites on the I-Ak
molecule . Several earlier studies (25-28) had shown that the bm12 mutation (at
residues 67, 70, and 71 of the A, polypeptide) had a substantial impact on
antigen-presenting capability and in vivo immune responses. Direct comparisons
of the ability of B6 and bm12 cells to present antigen to either B6- or bm12-
derived T cell clones indirectly indicated the existence of at least two T cell
recognition sites on the I-A' molecule (29, 30). Functional studies of a limited
number of site-directed Ab mutants (20) have revealed that even those substitu-
tions that failed to alter serologic reactivity ofthe molecule did affect the ability
of some Tcells to recognize the molecule. Lechler et al. (31) have examined the
separate contributions ofthe NH2-and COOH-terminal halves ofthe A, 3, domain
to the formation of epitopes required for recognition ofantigen by a panel of I-
A-restricted T hybridomas. They found that both halves of the As, domain
influenced the antigen-presentation capability of the I-A molecule. Thus, it
appears either that recognitionbyTcellsis moresensitive to structural alterations
than recognition by antibodies or that at least some T cell epitopes comprised
portions of the I-A molecule not directly involved in recognition by antibodies.BECK ET AL.
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The absence of x-ray crystallographic and other physicochemical data on the
secondary and tertiary structure of MHC class II molecules limits the scope of
the inferences that can be drawn on the effects of these mutations on the
structureandfunction ofthe I-A molecule. Analysis oftheseserologically selected
mutants has demonstrated that the region encompassing positions 61-70 of the
Ak 9 polypeptide is serologically dominant. Substitutions in this region also can
have dramatic effects on the ability of the molecule to be recognized by T cells.
Studies of variant cell lines generated by site-directed mutagenesis and DNA-
mediated gene transfer will be useful to examine the extent to which the other
allelically variable regions are involved in determining either serologically or
functionally important sites on the I-A molecule.
Summary
We have produced a series of in vitro serologically selected cell lines that
express mutant I-Ak molecules. In this report we describe the DNA sequence
analysis of the Ak gene of four cell lines that express serologically altered Ak k
polypeptides in association with wild-type Aa polypeptides. Each of the major
serologic epitopes on the A,k e polypeptide has been altered in one or more of the
four mutants. In addition, the four mutants exhibit a broad spectrum of func-
tional defects when used to stimulate a panel of T hybridomas of various
specificities. The DNAsequence analysis revealed that each mutant hadsustained
a single nucleotide substitution resulting in a single amino acid substitution . All
four independent substitutions occurred within or near the third of the four
variable regions defined in the #, domain of the A# polypeptide by allelic
comparisons. These data strongly suggest that the third variable region is the
major determinant of alloantigenicity on the A' polypeptide.
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